Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|October 23, 2025
Glutamine synthetase loss in β-catenin-mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogrammingEvan R Delgado, Panari Patel, Junyan Tao, et al.Hepatology (Baltimore, Md.)|July 18, 2017
MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in miceHeng Wu, Junyan Tao, Xiaolei Li, et al.The American Journal of Pathology|February 23, 2019
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human HepatoblastomaJie Zhang, Pin Liu, Junyan Tao, et al.The American Journal of Pathology|February 23, 2019
β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma PathogenesisQian Min, Laura Molina, Jing Li, et al.Elife|October 5, 2021
β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reactionShikai Hu, Jacquelyn O Russell, Silvia Liu, et al.Molecular Cancer Therapeutics|July 9, 2016
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse OriginShanthi Ganesh, Martin L Koser, Wendy A Cyr, et al.Hepatology Communications|September 10, 2021
Oncogenic Activity of Solute Carrier Family 45 Member 2 and Alpha-Methylacyl-Coenzyme A Racemase Gene Fusion Is Mediated by Mitogen-Activated Protein KinaseZe-Hua Zuo, Yan-Ping Yu, Bao-Guo Ren, et al.JHEP Reports : Innovation in Hepatology|November 25, 2024
Development of mutated β-catenin gene signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCCBrandon M Lehrich, Junyan Tao, Silvia Liu, et al.Cellular and Molecular Gastroenterology and Hepatology|July 22, 2025
Hepatic Ketogenesis Regulates Lipid Homeostasis Via ACSL1-Mediated Fatty Acid PartitioningRaja Gopal Reddy Mooli, Yerin Han, Ericka J Fiorenza, et al.Journal of Experimental & Clinical Cancer Research : CR|June 2, 2022
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human diseaseAntonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.Pageof 10